One small city's bid to rescue its health finances has transformed the way health care is managed across China. Chris McCall ...

A new study published in The Lancet journal showed that Gepotidacin was non-inferior to the standard treatment of ceftriaxone ...

Overweight patients given an experimental weight loss drug being developed by China's Sciwind Biosciences lost an average of ...

Tom McAndrew, a computational scientist and associate professor in Lehigh's College of Health, recently published a paper in ...

Amycretin is a unimolecular long-acting GLP-1 and amylin receptor agonist under development by Novo Nordisk, to provide an ...

CHICAGO -- A once-weekly basal insulin had similar safety and efficacy to a daily insulin option, a series of trials from the ...

Michelle Monje is the Milan Gambhir Professor of Pediatric Neuro-Oncology at Stanford University, CA, USA, and a Howard ...

The hard lessons the party has learned since Iraq point to one conclusion: Launching a new Middle East war would be a ...

Novo Nordisk on Friday said full results from early-stage trials show that its experimental drug, amycretin, helped ...

The National Institutes of Health office responsible for issuing federal guidelines related to treatment of HIV and AIDS ...

A new study of more than 13 million people in England has found no evidence to suggest mild COVID-19 infection may cause long ...

Eli Lilly and Company (NYSE: LLY) today announced detailed results from QWINT-1, QWINT-3, and QWINT-4 Phase 3 clinical trials ...